M Sea Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 05-12-2024
- Paid Up Capital ₹ 1.97 Cr
as on 05-12-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.67 Cr
as on 05-12-2024
- Revenue 27.02%
(FY 2022)
- Profit 14.66%
(FY 2022)
- Ebitda 15.50%
(FY 2022)
- Net Worth 1.75%
(FY 2022)
- Total Assets 17.68%
(FY 2022)
About M Sea Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.97 Cr.
The company currently has active open charges totaling ₹12.67 Cr.
Ajay Agarwal, Krishnamoorthy Chandru, Selvaraj Kumar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74900HP2015PTC000911
- Company No.
000911
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Sirmaur, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at M Sea Pharmaceuticals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Agarwal  | Director | 22-Feb-2018 | Current |
| Krishnamoorthy Chandru | Director | 01-Apr-2015 | Current |
| Selvaraj Kumar | Director | 19-Nov-2015 | Current |
| Harinath Harinath | Director | 19-Nov-2015 | Current |
| Shailender Kumar | Director | 31-Mar-2017 | Current |
| Manish Agarwal | Director | 13-Nov-2018 | Current |
Financial Performance of M Sea Pharmaceuticals.
M Sea Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27.02% increase. The company also saw a substantial improvement in profitability, with a 14.66% increase in profit. The company's net worth moved up by a moderate rise of 1.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M Sea Pharmaceuticals?
In 2022, M Sea Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
New Medicon Pharma Lab Private LimitedActive 18 years 8 monthsSelvaraj Kumar and Harinath Harinath are mutual person
Enerbay Lifesciences Private LimitedActive 1 year 8 monthsKrishnamoorthy Chandru is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 12 May 2021 | ₹7.82 Cr | Open |
Others Creation Date: 31 Aug 2018 | ₹2.51 Cr | Open |
Others Creation Date: 30 Jan 2016 | ₹2.35 Cr | Open |
How Many Employees Work at M Sea Pharmaceuticals?
Unlock and access historical data on people associated with M Sea Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M Sea Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M Sea Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
